Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

615 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.
Groh V, Wu J, Yee C, Spies T. Groh V, et al. Among authors: yee c. Nature. 2002 Oct 17;419(6908):734-8. doi: 10.1038/nature01112. Nature. 2002. PMID: 12384702
API5 confers tumoral immune escape through FGF2-dependent cell survival pathway.
Noh KH, Kim SH, Kim JH, Song KH, Lee YH, Kang TH, Han HD, Sood AK, Ng J, Kim K, Sonn CH, Kumar V, Yee C, Lee KM, Kim TW. Noh KH, et al. Among authors: yee c. Cancer Res. 2014 Jul 1;74(13):3556-66. doi: 10.1158/0008-5472.CAN-13-3225. Epub 2014 Apr 25. Cancer Res. 2014. PMID: 24769442 Free PMC article.
Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
Iyer JG, Afanasiev OK, McClurkan C, Paulson K, Nagase K, Jing L, Marshak JO, Dong L, Carter J, Lai I, Farrar E, Byrd D, Galloway D, Yee C, Koelle DM, Nghiem P. Iyer JG, et al. Among authors: yee c. Clin Cancer Res. 2011 Nov 1;17(21):6671-80. doi: 10.1158/1078-0432.CCR-11-1513. Epub 2011 Sep 9. Clin Cancer Res. 2011. PMID: 21908576 Free PMC article.
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.
Li Y, Bleakley M, Yee C. Li Y, et al. Among authors: yee c. J Immunol. 2005 Aug 15;175(4):2261-9. doi: 10.4049/jimmunol.175.4.2261. J Immunol. 2005. PMID: 16081794
Another LAP in the race.
Lee SM, Yee C. Lee SM, et al. Among authors: yee c. Cancer Discov. 2012 Feb;2(2):107-9. doi: 10.1158/2159-8290.CD-12-0010. Cancer Discov. 2012. PMID: 22585852
Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses.
Abdul-Alim CS, Li Y, Yee C. Abdul-Alim CS, et al. Among authors: yee c. J Immunol. 2010 Jun 1;184(11):6514-21. doi: 10.4049/jimmunol.0900448. Epub 2010 May 7. J Immunol. 2010. PMID: 20483791 Free PMC article.
CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors.
Shah KV, Chien AJ, Yee C, Moon RT. Shah KV, et al. Among authors: yee c. J Invest Dermatol. 2008 Dec;128(12):2870-9. doi: 10.1038/jid.2008.170. Epub 2008 Jun 19. J Invest Dermatol. 2008. PMID: 18563180 Free PMC article.
IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes.
Li Y, Yee C. Li Y, et al. Among authors: yee c. Blood. 2008 Jan 1;111(1):229-35. doi: 10.1182/blood-2007-05-089375. Epub 2007 Oct 5. Blood. 2008. PMID: 17921346 Free PMC article.
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.
Goodridge JP, Lee N, Burian A, Pyo CW, Tykodi SS, Warren EH, Yee C, Riddell SR, Geraghty DE. Goodridge JP, et al. Among authors: yee c. J Immunol. 2013 Aug 15;191(4):1567-77. doi: 10.4049/jimmunol.1300080. Epub 2013 Jul 12. J Immunol. 2013. PMID: 23851683 Free PMC article.
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
Pollack SM, Jungbluth AA, Hoch BL, Farrar EA, Bleakley M, Schneider DJ, Loggers ET, Rodler E, Eary JF, Conrad EU 3rd, Jones RL, Yee C. Pollack SM, et al. Among authors: yee c. Cancer. 2012 Sep 15;118(18):4564-70. doi: 10.1002/cncr.27446. Epub 2012 Feb 22. Cancer. 2012. PMID: 22359263 Free PMC article.
615 results
Jump to page